Lizhu Pharma Sells Medical Devices Business
-
Last Update: 2020-05-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Pharmaceutical Network May 28th, May 26th evening, Lizhu Pharmaceuticals announced that the company to independent third party Genesis Medtech sold a total of 19.99 percent of the medical device products business Nico Company, the price of 122 million yuanThe sale is expected to add net profit of about RMB85.24 millionThe announcement shows that the sale of the company's shares of the Nico company for theof Lizhu, its main lying in the production and sale ofproducts, the sale of equity effectively realized the company has invested in the project exit, so that the company more focused on innovative pharmaceutical industryafter preliminary estimates, after deducting the company's investment costs, taxes and other related expenses, the sale of equity is expected to increase the company's net profit attributable to shareholders of the parent company of about 85.2399 million yuan, the company's financial position and operating results for the current year does not have a significant impact, the final realized net profit will be the company's 2020 audit report.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
